Le Lézard
Classified in: Health, Sports and recreation
Subjects: NPT, CSR

Aerie® Partners With Bright Pink® For The Tenth Year And Will Surpass Two Million Dollars In Donations!


CHICAGO, Sept. 20, 2019 /PRNewswire/ -- Bright Pink, a national non-profit organization focusing on the prevention and early detection of breast and ovarian cancer in women, celebrates ten years of partnering with Aerie in support of Breast Cancer Awareness Month and will cross the two million dollar mark in donations to fuel Bright Pink's mission. Aerie will offer an Aerie limited-edition move sports bra, Aerie Limited-Edition Play High Waisted Legging and Aerie Limited-Edition Hoodie. 100% of sales will benefit Bright Pink. The "Take Care of Your Girls" campaign will run in Aerie stores and online at www.aerie.com beginning September 19, 2019 until supplies last.

In addition, Aerie will introduce several opportunities for customers to help the cause, including in-store marketing encouraging shoppers to complete Bright Pink's award-winning Assess Your Risk quiz. Aerie is donating $1 for every Bright Pink Assess Your Risk completion via assessyourrisk.org/aerie. Assess Your Risk is a digital quiz that collects risk factors (lifestyle, personal and familial health history) to provide a personalized risk assessment for breast and ovarian cancers. Aerie is also giving customers the opportunity to donate to Bright Pink at checkout in-stores.

Bright Pink will promote Aerie's limited-edition products and partnership with the brand via email on their homepage, with a social media sweepstakes and with a co-branded blog article, REAL Self-Love: 8 Actions to Take to Reduce Your Risk of Breast & Ovarian Cancer. The partnership and campaign aims to empower women to move beyond breast cancer awareness and inspire them to take action to reduce their risk and manage their health proactively, while also raising funds to fuel Bright Pink's life-saving, innovative, personalized education programs.

"Bright Pink is so proud to team up with Aerie for a tenth year this fall to spread our message of Breast & Ovarian Cancer prevention to customers nationwide. Through the generosity of Aerie's continued commitment to our mission we will have the power to educate and equip thousands of women on their breast and ovarian cancer risk, and together we will create a more beautiful and brighter future," said Bright Pink CEO, Katie Thiede.

"Aerie is so proud to be celebrating a milestone year supporting Bright Pink, and its life-saving mission," commented Jennifer Foyle, Aerie Global Brand President. "It is incredibly gratifying to know that over the last ten years we have empowered millions of women within our #AerieREAL community to be proactive about their health and recognize the importance of self-wellness."

The partnership includes several components:

Aerie and Bright Pink will promote the program through social media, customer e-mails and in-store marketing. For more information, visit www.aerie.com and www.brightpink.org.

About Aerie
Aerie is a lifestyle brand offering intimates, apparel, activewear and swim collections. With the #AerieREALtm movement, Aerie celebrates its community by advocating for body positivity and the empowerment of all women. Aerie believes in inspiring customers to love their real selves, inside and out. Retouching-free since 2014. Visit www.aerie.com to learn more. Let the Real You Shine®.

About Bright Pink®
Bright Pink is a national non-profit focused on the prevention and early detection of breast and ovarian cancer. The organization's mission is to help save lives from breast and ovarian cancer by empowering women to know their risk and manage their health proactively. For more information, visit BrightPink.org.

Tara Cruise
Corporate Partnerships Manager
Bright Pink
[email protected]

Colleen Ruggiero
Public Relations
Aerie®
[email protected]

SOURCE Bright Pink; Aerie


These press releases may also interest you

at 07:35
Agenus Inc. ("Agenus") , a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Agenus executives...

at 07:34
Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An," the "Company" or the "Group," HKEX: 2318; SSE: 601318) today announced its first quarter financial results for the three months ended March 31, 2024....

at 07:31
Tharimmune, Inc. ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation & immunology, announced today an option agreement for an...

at 07:30
KFSH&RC participates as a strategic partner in the Saudi American Healthcare Forum, which will take place on April 25th under the patronage of the Ministry of Health in Riyadh. This forum aims to discuss the primary healthcare challenges facing the...

at 07:30
Factor Bioscience Inc., a Cambridge-based biotechnology company focused on...

at 07:15
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today unveiled multiple pipeline programs ahead of the 27th ASGCT Annual meeting on May 7 - 11, 2024 in Baltimore, MD....



News published on and distributed by: